- BMSystems will participate to BIO in Boston, June 18-21; and Bio-Europe in Hamburg November, 12-14.
- Munich,may 11-12, 2012: BMSystems' CSO François Iris, is invited as session chairman to the 8th International Workshop on Computational Neuropsychiatry: Sleep, Affective disorders and Schizophrenia - An integrated view.
- Press-Release-Feb-2012: Pherecydes Pharma secures a €1.2-million Defense agency funding for evaluating the use of bacteriophages against infected, antibiotic resistant burns.
Downloads
BMSystems European Commission Conference Presentation
The EC "From Systems Biology to Systems Medicine" report
Industrial biotech World cluster
Spin-off sites
Bio-Modeling Systems: The Heuristic Systems Biology Company that delivers.
BMSystems is the first and to date the only integrative systems biology company that succeeded to create in-silico heuristic models validated in-vivo. These outputs led to discoveries, patents, or operational businesses through its innovative business model, in the fields of infectious diseases, neurology, psychiatry, oncology and industrial biotech.
The life-modeling issue
|
BMSystems solution We invented CADI*™ CADI™ is the first, and to date, the only solution that succeeded to create in-vivo validated in-silico heuristic models of complex human pathologies & physiological processes. Since 2004, BMSystems implements its disruptive collaborative research strategy and its innovative business model to generate scientific and business successes. *CADI™ : Computer Assisted Deductive Integration |
